Stanley M Marks Blood Cancer Research Fund

Analysis

Stanley M Marks Blood Cancer Research Fund is a registered charity in United States, based in Pittsburgh, PA. It received its IRS tax-exemption ruling in December 2018, 8 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Stanley M Marks Blood Cancer Research Fund reported income of $859k and spending of $866k, spending 101% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $507k to $859k (+70%), an average of +14% a year. The sharpest change came in the year to December 2021, when income rose by 77%. Over the whole period it spent 99% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Stanley M Marks Blood Cancer Research Fund sits at the 62nd percentile: it is larger than about 62% of them. Against every charity in United States with reported income it ranks in the 77th percentile, and in the 76th percentile within PA. Charities of a similar size with the same main cause include Carlos Otis Stratton Mountain Clinic Inc ($859k), Myalgic Encephalomyelitis Action Network Inc ($860k) and Mental Health Associates of the Triad ($859k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 96% of the total. At year end it held assets of $47k against liabilities of $0, net assets of $47k.